Biofeedback Gait Training on Gait Quality in Stroke

February 22, 2025 updated by: Yea-Ru Yang, National Yang Ming Chiao Tung University

Effects of Biofeedback Gait Training on Gait Quality Post-stroke

Post-stroke gait dysfunction is characterized by reduced gait velocity and stride length, along with gait asymmetry and instability. Gait asymmetry and instability are considered as indicators for gait quality, which affect independence and quality of life in individual with stroke. Previous studies have suggested that gait biofeedback is a promising strategy for enhancing the efficacy of post-stroke gait training. However, there is insufficient evidence on the effects of kinematic biofeedback gait training on gait asymmetry and instability in individuals with stroke. Therefore, the purpose of this study is to investigate the effects of real-time kinematic gait biofeedback training on gait quality in individuals with stroke.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 112
        • Recruiting
        • Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • First stroke
  • Stroke onset time ≥ 6 months
  • Functional Ambulation Category ≥3
  • Passive range of motion of affected hip extension is at least 10 degrees
  • Mini-Mental State Measurement score ≥ 24 points

Exclusion Criteria:

  • Modified Ashworth Scale of affected ankle plantar flexors ≥ 2
  • Muscle strength of affected ankle plantar flexors via Manual Muscle Testing ≤ 1
  • Uncorrected auditory impairment
  • Severe cardiovascular disease or uncontrolled hypertension
  • Other orthopedic diseases that may affect walking ability
  • Other neurological disease except stroke

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gait training with biofeedback group
The intervention is a 60-minute session and 3 sessions/week, totaling 4 weeks.
Gait training include treadmill and overground walking. The biofeedback device system will provide real-time feedback on hip extension angles.
Active Comparator: Gait training without biofeedback group
The intervention is a 60-minute session and 3 sessions/week, totaling 4 weeks.
Gait training include treadmill and overground walking.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait symmetry
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using GAITRite system to measure the symmetry of saptiotemporal parameters
Change from baseline at 4 weeks after training and 4 weeks follow-up
Gait variability
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using GAITRite system to measure the coefficient of variation of saptiotemporal parameters
Change from baseline at 4 weeks after training and 4 weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Propulsive force
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using Force plate to measure the ground reaction force
Change from baseline at 4 weeks after training and 4 weeks follow-up
Gait performance
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using the GAITRite system to evaluate saptiotemporal parameters
Change from baseline at 4 weeks after training and 4 weeks follow-up
Berg Balance Scale
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using Berg Balance Scale to evaluate balance ability
Change from baseline at 4 weeks after training and 4 weeks follow-up
Activities-specific Balance Confidence Scale
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using Activities-specific Balance Confidence Scale to evaluate individual's balance confidence in performing daily activities
Change from baseline at 4 weeks after training and 4 weeks follow-up
Taiwan Chinese version Falls Efficacy Scale
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using Taiwan Chinese version Falls Efficacy Scale to evaluate concerns about falling
Change from baseline at 4 weeks after training and 4 weeks follow-up
Frenchay Activities Index
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using Frenchay Activities Index to measure individual's capacity to perform instrumental activities of daily living
Change from baseline at 4 weeks after training and 4 weeks follow-up
Stroke Impact Scale
Time Frame: Change from baseline at 4 weeks after training and 4 weeks follow-up
Using Stroke Impact Scale to evaluate disability and quality of life after stroke
Change from baseline at 4 weeks after training and 4 weeks follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

June 30, 2024

First Submitted That Met QC Criteria

June 30, 2024

First Posted (Actual)

July 8, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 22, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Gait training with biofeedback

Subscribe